SEC-sourced researchBeta
CVS
CVS HEALTH Corp
Company comparison ↗
Data passport
- CIK
- 0000064803
- Exchange
- NYSE
- Business activity
- — · SIC 5912
- Financial inputs
- 6/6
- Filing date
- Feb 10, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 357,776,000,000.0000 | Feb 10, 2026 |
| December 2024 | 372,809,000,000.0000 | Feb 10, 2026 |
| December 2025 | 402,067,000,000.0000 | Feb 10, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 402,067,000,000.0000 | 1,768,000,000.0000 | 10,639,000,000.0000 | 253,538,000,000.0000 | 178,156,000,000.0000 | Feb 10, 2026 |
| December 2024 | 372,809,000,000.0000 | 4,614,000,000.0000 | 9,107,000,000.0000 | 253,215,000,000.0000 | 177,485,000,000.0000 | Feb 10, 2026 |
| December 2023 | 357,776,000,000.0000 | 8,344,000,000.0000 | 13,426,000,000.0000 | — | — | Feb 10, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $402.07B | December 2025 | Feb 10, 2026 | 10-K |
| Previous period revenueRevenues | $372.81B | December 2024 | Feb 10, 2026 | 10-K |
| Net incomeNetIncomeLoss | $1.77B | December 2025 | Feb 10, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $10.64B | December 2025 | Feb 10, 2026 | 10-K |
| Total assetsAssets | $253.54B | December 2025 | Feb 10, 2026 | 10-K |
| Total liabilitiesLiabilities | $178.16B | December 2025 | Feb 10, 2026 | 10-K |